Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

1. Million Women Study Collaborators . Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419–427.

2. Million Women Study Collaborators . Patterns of use of hormone replacement therapy in one million women in Britain, 1996–2000. BJOG 2002; 109: 1319–1330.

3. Collaborative Group on Hormonal Factors for Breast Cancer , Breast cancer and hormone replacement therapy: collaborative reanalysis from 51 individual epidemiological studies. Lancet 1997; 350: 1047–1060.

4. Chlebowski

Hendrix

Lander

Women's Health Initiative Randomised Trial . Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. JAMA 2003; 289: 3243–3253.

5. www.whi.org (accessed 12.8.03).

6. Lundström

Christow

Kersemaekers

. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. Am J Obstet Gynecol 2002; 186: 717–722.

7. Nanda

Bastian

Schultz

, Hormone replacement therapy and the risk of death from breast cancer: A systematic review. Am J Obstet Gynecol 2002; 186: 325–334.

8. www.mhra.gov.uk (accessed 12.8.03).

9. Marsden

Sacks

The national randomised trial of hormone replacement therapy in women with a history of early stage breast cancer: an update. J Br Menopause Soc 2002; 8: 129.

The Million Women Study and Breast Cancer

Abstract

Get full access to this article

References